Moreover, we substantiated the existence of predicted m6A sites in Atp13a2 (Park9) (Fig. 5j)44, an ALS risk gene not previously shown to have m6A modifications in MNs. Here, ATP13A2 is linked to amyotrophic lateral sclerosis.